arrow
返回

Osteogenesis imperfecta

delete2017-08-18
delete537
PRE
AI
J
Joan C. Marini *
A
Antonella Forlino
H
Hans Peter Bächinger
N
Nick Bishop
P
Peter H. Byers
A
Anne De Paepe
F
François Fassier
N
Nadja Fratzl‐Zelman
K
Kenneth M. Kozloff
D
Deborah Krakow
K
Kathleen Montpetit
O
Oliver Semler
DOI:10.1038/nrdp.2017.52delete
delete原文链接
delete分享
delete收藏
摘要

摘要

En 中文
Skeletal deformity and bone fragility are the hallmarks of the brittle bone dysplasia osteogenesis imperfecta. The diagnosis of osteogenesis imperfecta usually depends on family history and clinical presentation characterized by a fracture (or fractures) during the prenatal period, at birth or in early childhood; genetic tests can confirm diagnosis. Osteogenesis imperfecta is caused by dominant autosomal mutations in the type I collagen coding genes (COL1A1 and COL1A2) in about 85% of individuals, affecting collagen quantity or structure. In the past decade, (mostly) recessive, dominant and X-linked defects in a wide variety of genes encoding proteins involved in type I collagen synthesis, processing, secretion and post-translational modification, as well as in proteins that regulate the differentiation and activity of bone-forming cells have been shown to cause osteogenesis imperfecta. The large number of causative genes has complicated the classic classification of the disease, and although a new genetic classification system is widely used, it is still debated. Phenotypic manifestations in many organs, in addition to bone, are reported, such as abnormalities in the cardiovascular and pulmonary systems, skin fragility, muscle weakness, hearing loss and dentinogenesis imperfecta. Management involves surgical and medical treatment of skeletal abnormalities, and treatment of other complications. More innovative approaches based on gene and cell therapy, and signalling pathway alterations, are under investigation.
Keyword:
QUALITY-OF-LIFE
BONE MORPHOGENETIC PROTEIN-1
EHLERS-DANLOS-SYNDROME
INTRAVENOUS PAMIDRONATE THERAPY
GROWTH-FACTOR-BETA
MOUSE MODEL
I COLLAGEN
ENDOPLASMIC-RETICULUM
BRUCK-SYNDROME
SCLEROSTIN ANTIBODY
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

N
Nature Reviews Disease Primers
IF:
60.6
论文数:
658
被引数:
3.8W

机构

N
national institutes of health (nih) - usa
学者数:
10.3W
论文数: 8.2W
被引数: 111
G
Ghent University
学者数:
1.5K
论文数: 529
被引数: 0
U
University of Sheffield
学者数:
802
论文数: 336
被引数: 0
W
wgkk - hanusch hospital
学者数:
574
论文数: 483
被引数: 0
U
University of Pavia
学者数:
418
论文数: 178
被引数: 0
L
ludwig boltzmann institute
学者数:
6
论文数: 5
被引数: 0
U
university of washington
学者数:
2.9K
论文数: 943
被引数: 0
M
mcgill university
学者数:
1.8K
论文数: 704
被引数: 0
学者 查看更多机构
引用论文

引用论文

Green synthesis of gold nanoparticle/gelatin/protein nanogels with enhanced bioluminescence/biofluorescence
err2019-12-01
err0
PREAI
errI-Hsiu Chen; Yu-Fon Chen; Jhih-Han Liou; Jinn-Tsyy Lai; Chia-Chen Hsu; Nai-Yi Wang; Jeng-Shiung Jan
err分享
err收藏
Synthesis and porous h-BN 3D architectures for effective humidity and gas sensors
err2016-01-01
err0
PREAI
errChandkiram Gautam; Chandra Sekhar Tiwary; Leonardo D. Machado; Sujin Jose; Sehmus Ozden; Santoshkumar Biradar; Douglas S. Galvao; Rakesh K. Sonker; B. C. Yadav; Robert Vajtai; P. M. Ajayan
err分享
err收藏
Verification and Design Methods for the BrainScaleS Neuromorphic Hardware System
err2020-07-09
err0
errOAAI
errAndreas Grübl; Sebastian Billaudelle; Benjamin Cramer; Vitali Karasenko; Johannes Schemmel
err分享
err收藏
Lanthanide-Induced Photoluminescence in Lead-Free Cs2AgBiBr6 Bulk Perovskite: Insights from Optical and Theoretical Investigations
err2020-09-30
err0
PREAI
errFabian Schmitz; Kunping Guo; Jonas Horn; Roberto Sorrentino; Gioele Conforto; Francesco Lamberti; Rosaria Brescia; Filippo Drago; Mirko Prato; Zhubing He; Umberto Giovanella; Franco Cacialli; Derck Schlettwein; Daniele Meggiolaro; Teresa Gatti
err分享
err收藏
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
err2016-10-20
err1.1K
errOAAI
errCosman, F.; Crittenden, D. B.; Adachi, J. D.; Binkley, N.; Czerwinski, E.; Ferrari, S.; Hofbauer, L. C.; Lau, E.; Lewiecki, E. M.; Miyauchi, A.; Zerbini, C. A. F.; Milmont, C. E.; Chen, L.; Maddox, J.; Meisner, P. D.; Libanati, C.; Grauer, A.
err分享
err收藏
err分享
err收藏
Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength
err2009-12-02
err126
errOAAI
errKozloff, KM; Carden, A; Bergwitz, C; Forlino, A; Uveges, TE; Morris, MD; Marini, JC; Goldstein, SA
err分享
err收藏
How Tough Is Brittle Bone? Investigating Osteogenesis Imperfecta in Mouse Bone
err2014-01-13
err124
errOAAI
errCarriero, Alessandra; Zimmermann, Elizabeth A.; Paluszny, Adriana; Tang, Simon Y.; Bale, Hrishikesh; Busse, Bjorn; Alliston, Tamara; Kazakia, Galateia; Ritchie, Robert O.; Shefelbine, Sandra J.
err分享
err收藏
Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement
err2009-12-04
err175
PREAI
errLetocha, AD; Cintas, HL; Troendle, JF; Reynolds, JC; Cann, CE; Chernoff, EJ; Hill, SC; Gerber, LH; Marini, JC
err分享
err收藏
学者 查看更多内容